Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on March 9, 2018, reporting events occurring on March 7, 2018. The filing serves to announce the company's financial and operating results for the three-month and 12-month periods ended December 31, 2017.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus prior periods. It solely references the issuance of a press release containing the Fourth Quarter and Full Year 2017 financial results.
Guidance, Outlook, and Risks
The filing includes a Regulation FD disclosure regarding the press release. It explicitly states that the information in this Item shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference in any filing under the Securities Act of 1933, except as expressly set forth by specific reference. No specific guidance, outlook, or risk factors are detailed in the text of this 8-K.
Investor Verification Checklist
- Verify the correct registrant name is Second Sight Medical Products, Inc., not Vivani Medical, Inc.
- Review Exhibit 99.1 (Press Release issued March 7, 2018) for actual financial figures, as they are absent from the 8-K body.
- Confirm the reporting period covers Q4 and Full Year 2017.
- Note that the financial data in this filing is not deemed "filed" under Section 18 of the Exchange Act.